The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.
about
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domainsReliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virusA new insight into hepatitis C vaccine developmentMechanisms of viral entry: sneaking in the front doorDC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2Phospholipid scramblase 1 mediates hepatitis C virus entry into host cellsEntry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptorIdentification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope proteinHepatitis C virus proteinsThe tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virusCoxsackievirus entry across epithelial tight junctions requires occludin and the small GTPases Rab34 and Rab5Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivityInfectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexesInitiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type IClaudin-6 and claudin-9 function as additional coreceptors for hepatitis C virusPotential cellular receptors involved in hepatitis C virus entry into cellsTranscriptome analysis of a cnidarian-dinoflagellate mutualism reveals complex modulation of host gene expression.Hepatitis C virus relies on lipoproteins for its life cycleHost restriction factors for hepatitis C virusStatus of hepatitis C virus vaccination: Recent updateRoles of lipoprotein receptors in the entry of hepatitis C virusHost-Targeting Agents to Prevent and Cure Hepatitis C Virus InfectionHepatitis C virus comes for dinner: How the hepatitis C virus interferes with autophagyGenetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignCuring a viral infection by targeting the host: the example of cyclophilin inhibitorsHepatitis C virus molecular evolution: transmission, disease progression and antiviral therapyImpact of lipids and lipoproteins on hepatitis C virus infection and virus neutralizationMurine models of hepatitis C: what can we look forward to?Autophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseasesDirect acting antivirals for the treatment of chronic viral hepatitisThe hepatitis C virus glycan shield and evasion of the humoral immune responseNeutralizing antibody response to hepatitis C virusDecoding protein networks during virus entry by quantitative proteomicsScavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes.An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing AntibodiesMonoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope GlycoproteinTetraspanins in viral infections: a fundamental role in viral biology?Analysis of a Highly Flexible Conformational Immunogenic Domain A in Hepatitis C Virus E2Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry.Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry
P2860
Q21089621-DF4D8443-66CA-4940-8DA0-EFAD5ED7968AQ21090530-42ADA705-D523-4CA5-B745-AEAECC20EFCBQ21296858-690092ED-294E-4EA6-A906-7536C7F4E064Q22252690-2298949D-749B-4752-9522-814BB3221A23Q24296260-43D0E88A-C766-4F84-A760-C7DBF10D2CD1Q24318390-A0A4B2B9-44FA-4B12-B465-37715A49281CQ24336433-BCC40651-020F-4BE4-B3A4-F615EE2EFAABQ24338469-A2295B2D-57A6-4EA1-A4DD-AB05E2E5C81BQ24563969-658F55E1-91B3-43E5-BB04-F0923E13DF05Q24652906-A1E18901-003C-4EA5-9D24-5A4B0414C493Q24658142-BD037682-5541-4A94-9890-B2B3408FE1F3Q24672232-335209BA-C81A-4462-A562-65A24061BBEBQ24673768-0537A644-2562-4EEB-89F5-5ACFC6363619Q24676039-28B3D2BF-EF66-4CBB-8DB6-696DE12CB4E3Q24681592-DD9AD8F7-07A5-4CC2-A6D6-DE645D7703B7Q24795289-497673B3-F6CE-47E8-8D7B-F50D678005A5Q25255921-5BB8DA59-A6C7-4407-8B82-E32F77A286C3Q26766119-21980658-CD21-42CE-98D0-7632DA62CFEBQ26773258-EDDB7256-7CC4-4928-980D-DAFA92F261EAQ26774612-2E25EF16-A950-4B76-B8A4-5043F7DA8B3EQ26777338-47B9A5CE-7366-4401-844F-4550DD98CB14Q26779128-14A9884B-CCED-4F00-A219-ED23C16F6674Q26801207-3FEDA1A1-C6A4-44F1-BAE1-EADD75FD4120Q26801759-773482C4-7433-4F3B-8B95-13B3EB729808Q26828727-8F27998E-8BC8-422C-B61A-4E36BC6DD015Q26853500-14549C72-30AA-44FC-A694-0F36F5322381Q26864485-FBEEA3C6-7CA9-4665-90F6-287326269AC1Q26991875-83583180-A971-41D1-9881-FDFF0044E7EEQ26992256-CE126361-2209-4015-90C9-7254D1F70282Q27022216-0578F505-23C6-424E-8E8A-12F3BD6E9364Q27023390-B2AC9B1F-5EBC-401F-97A1-B4018BED5207Q27027484-50E667E2-EE9B-43BC-B259-67A515E0D220Q27469058-974C9508-0DB3-4511-B149-1767CFE4F676Q27469468-12FD3473-88AD-4A21-A618-68933419CFEDQ27469837-1FE17CD3-ECD2-4910-8105-2457A9C94EB0Q27470798-69047786-DA8D-4B86-86F3-307280B2BB23Q27470936-46360E00-98DC-4033-86A5-66F1B48A280CQ27472672-12E6D086-D9AE-4919-9F12-64604822DA5EQ27472768-271DD49B-BE89-4144-B2D7-91EFF0A151D8Q27472926-68AFA1E8-6AEB-4457-9555-AA9F7D455D7A
P2860
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The human scavenger receptor c ...... ptor for the hepatitis C virus
@nl
The human scavenger receptor c ...... tor for the hepatitis C virus.
@ast
The human scavenger receptor c ...... tor for the hepatitis C virus.
@en
The human scavenger receptor c ...... tor for the hepatitis C virus.
@en-gb
type
label
The human scavenger receptor c ...... ptor for the hepatitis C virus
@nl
The human scavenger receptor c ...... tor for the hepatitis C virus.
@ast
The human scavenger receptor c ...... tor for the hepatitis C virus.
@en
The human scavenger receptor c ...... tor for the hepatitis C virus.
@en-gb
prefLabel
The human scavenger receptor c ...... ptor for the hepatitis C virus
@nl
The human scavenger receptor c ...... tor for the hepatitis C virus.
@ast
The human scavenger receptor c ...... tor for the hepatitis C virus.
@en
The human scavenger receptor c ...... tor for the hepatitis C virus.
@en-gb
P2093
P2860
P3181
P356
P1433
P1476
The human scavenger receptor c ...... tor for the hepatitis C virus.
@en
P2093
Alessandra Vitelli
Alfredo Nicosia
Cinzia Traboni
Elisa Scarselli
Gessica Filocamo
Helenia Ansuini
Raffaele Cerino
Riccardo Cortese
Rosa Maria Roccasecca
Stefano Acali
P2860
P304
P3181
P356
10.1093/EMBOJ/CDF529
P407
P577
2002-10-01T00:00:00Z